MYLAN-RIVASTIGMINE PATCH 5
MYLAN-RIVASTIGMINE PATCH 5
Approved
DIN Number
02423413
Drug Class
Human
Market Date
Dec 5, 2016
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02423413
AIG Number0140521007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06DA03 RIVASTIGMINE
Product Specifications
Dosage FormPatch
Route of AdministrationTransdermal
AHFS Classification12:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIVASTIGMINEActive
Strength: 4.6 MG / 24 HOUR
Monograph: RIVASTIGMINE